Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 72

Sort by

Sort Order Select

Journal Articles

Prognostic Impact of TP53 Mutation in Adult Acute Lymphoblastic Leukemia Treated with Pediatric-Inspired Regimen

Jiawang Ou, Xiuli Xu, Ya Zhou, Qifa Liu, Hongsheng Zhou

Blood (2023) 142 (Supplement 1): 6066.

https://doi.org/10.1182/blood-2023-186286

Published: 2023

Journal Articles

Treatment of Acute Lymphoblastic Leukemia with PDT Regimen Improves the Prognosis of Newly Diagnosed Central Nervous System Leukemia

Haimei Liang, Qifa Liu, Hongsheng Zhou

Blood (2023) 142 (Supplement 1): 5899.

https://doi.org/10.1182/blood-2023-188418

Published: 2023

Journal Articles

CRM1/XPO1-FOXO1 Pathway Is Associated with Clinical Outcome and Represents a Promising Target in B-Cell Acute Lymphocytic Leukemia

Shiyu Deng, Jiawang Ou, Cai Zihong, Zicong Huang, Jia Li, Qifa Liu, Hongsheng Zhou

Blood (2023) 142 (Supplement 1): 4253.

https://doi.org/10.1182/blood-2023-188459

Published: 2023

Journal Articles

Evaluation of the Effectiveness of Antifungal Prophylaxis in Adult Acute Lymphoblastic Leukemia during Induction Chemotherapy

Yang Zhou, Junjie Chen, Cai Zihong, Qifa Liu, Hongsheng Zhou

Blood (2023) 142 (Supplement 1): 4241.

https://doi.org/10.1182/blood-2023-188442

Published: 2023

Journal Articles

Allo-HSCT Improved Outcome of High Risk ALL in Pediatric-Inspired PDT-ALL-2016 Cohort

Junjie Chen, Zhixiang Wang, Qifa Liu, Hongsheng Zhou

Blood (2023) 142 (Supplement 1): 2229.

https://doi.org/10.1182/blood-2023-185940

Published: 2023

Journal Articles

Frontline Combination of 3 rd Generation TKI Olverembatinib and Blinatumomab for Ph+/Ph-like ALL Patients

Ting Zhang, Kaibo Zhu, Cai Zihong, Ren Lin, Qifa Liu, Hongsheng Zhou

Blood (2023) 142 (Supplement 1): 1504.

https://doi.org/10.1182/blood-2023-186139

Published: 2023

Journal Articles

The Pediatric-Inspired Regimen Improved Quality and Quantity of Life for Patients with Acute Lymphoblastic Leukemia，Beyond Age, Risk Stratification, and Hematopoietic Stem Cell Transplantation

Junjie Chen, Zhixiang Wang, Qifa Liu, Hongsheng Zhou

Blood (2023) 142 (Supplement 1): 1466.

https://doi.org/10.1182/blood-2023-188479

Published: 2023

Journal Articles

Olverembatinib(HQP1351)-Based Therapy in Adults with Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Advanced Chronic Myeloid Leukemia: Results of the Real-Life Study

Ziyu Wen, Zhiping Fan, Qiang Wang, Xuan Zhou, Zherou He, Zicheng Gao, Hong Chen, Hanyin Liang, Dongmei Luo, Xiaoli Liu, Hongsheng Zhou, Qifa Liu, Na Xu

Blood (2023) 142 (Supplement 1): 4538.

https://doi.org/10.1182/blood-2023-181850

Published: 2023

Journal Articles

CD19-Specific CAR NK Cells Coexpressing IL-21 Exhibit Superior Expansion and Antitumor Activity Against CD19-Postive Lymphoma

Bailin He, Hong Chen, Shikai Deng, Chengyao Li, Na Xu, Xiaoli Liu, Hongsheng Zhou, Qifa Liu

Blood (2023) 142 (Supplement 1): 6824.

https://doi.org/10.1182/blood-2023-178289

Published: 2023

Journal Articles

Efficacy and Safety of TLR2 Co-Stimulated CAR T Cells in CD19-Positive Lymphoid Malignancies with Central Nervous System Involvement

Bailin He, Hongsheng Zhou, Ren Lin, Zhixiang Wang, Na Xu, Qiang Wang, Jing Sun, Xiaoli Liu, Peng Li, Qifa Liu

Blood (2023) 142 (Supplement 1): 3484.

https://doi.org/10.1182/blood-2023-184492

Published: 2023

Journal Articles

Maintenance Therapy with Chidamide Decreases the Relapse in Fusion Gene-Positive AML Patients with MRD-Positive or ELN-High Risk

Guopan Yu, Zhao Yin, Jixian Huang, Huiqing He, Xuejie Jiang, Hongsheng Zhou, Pengcheng Huang, Yu Zhang

Blood (2023) 142 (Supplement 1): 5862.

https://doi.org/10.1182/blood-2023-182621

Published: 2023

Journal Articles

Venetoclax in Combination with Homoharringtonine and Cytarabine in the Treatment of Relapsed/Refractory Early T-Cell Precursor Acute Lymphoblastic Leukaemia: A Single Arm, Multicenter, Prospective, Phase II, Pilot Trial

Wenjuan Yu, Hongsheng Zhou, Lijing Shen, Dong Chen, Xiang Zhang, Yanan Zhu, Xin Huang, Ying Lu, Jian Hou, Qifa Liu, Jie Jin

Blood (2022) 140 (Supplement 1): 3260–3261.

https://doi.org/10.1182/blood-2022-164933

Published: 2022

Journal Articles

Chemotherapy or Hematopoietic Stem Cell Transplantation in B-Lineage Acute Lymphoblastic Leukemia Patients Based on IKZF1 and MRD Status

Shiyu Deng, Jiawang Ou, Zicong Huang, Cai Zihong, Bingqing Tang, Xiuli Xu, Yiqian Liu, Zhengwei Wu, Qifa Liu, Hongsheng Zhou

Blood (2022) 140 (Supplement 1): 11856.

https://doi.org/10.1182/blood-2022-166780

Published: 2022

Journal Articles

Prognostic Significance of Epigenetic Modifiers Gene Mutations in Adult Acute Lymphoblastic Leukemia at Diagnosis

Jiawang Ou, Xiuli Xu, Zicong Huang, Shiyu Deng, Cai Zihong, Bingqing Tang, Xiaojie Liang, Zhengwei Wu, Yiqian Liu, Lingling Zhou, Qifa Liu, Hongsheng Zhou

Blood (2022) 140 (Supplement 1): 3475.

https://doi.org/10.1182/blood-2022-166404

Published: 2022

Journal Articles

Sustained Remission and Decreased Severity of CAR T-Cell Related Adverse Events: A Pivotal Study Report of CNCT19 (inaticabtagene autoleucel) Treatment in Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-Cell ALL) in China

Ying Wang, Xudong Wei, Dongmei Yan, Cheng Zhang, Hongsheng Zhou, Chunrong Tong, Heng Mei, Jie Jin, Ting Niu, Aibin Liang, Jienan Ren, Yiping Deng, Wei Jin, Yi Feng, Lin Shi, Yongzeng Wang, Changting Haudenschild, Lulu Lv, Jianxiang Wang

Blood (2022) 140 (Supplement 1): 1598–1600.

https://doi.org/10.1182/blood-2022-165002

Published: 2022

Journal Articles

Dynamics of Minimal Residual Disease Defines a Novel Risk-Classification and the Role of Allo-HSCT in Adult Ph-Negative B Cell Acute Lymphoblastic Leukemia

Cai Zihong, Bingqing Tang, Xiuli Xu, Zicong Huang, Qifa Liu, Hongsheng Zhou

Blood (2022) 140 (Supplement 1): 9205–9206.

https://doi.org/10.1182/blood-2022-165201

Published: 2022

Journal Articles

Metabolic Feature Profiling and Metabolic Vulnerability Targeting in B-Cell Lymphoblastic Leukemia

Xiaojie Liang, Bingqing Tang, Cai Zihong, Zicong Huang, Baiwei Luo, Bingyu Lin, Yunong Yang, Qifa Liu, Hongsheng Zhou

Blood (2022) 140 (Supplement 1): 6361–6362.

https://doi.org/10.1182/blood-2022-166637

Published: 2022

Journal Articles

HDACi Targets IKZF1 Deletion High-Risk Acute Lymphoblastic Leukemia By Inducing IKZF1 Expression and Rescuing IKZF1 Function in Vitro and In Vivo

Kangyu Huang, Bingqing Tang, Zihong Cai, Xianjun He, Qiuli Li, Nannan Liu, Dainan Lin, Xinhua Pan, Ce Shi, Zijie Long, Jinheng Wang, Yumin Hu, Peng Li, Qifa Liu, Hongsheng Zhou

Blood (2021) 138 (Supplement 1): 514.

https://doi.org/10.1182/blood-2021-152926

Published: 2021

Journal Articles

IKZF1deletions Coupled with CD20 Expression Represents a Novel High-Risk Subtype in Adult B-Cell Progenitor Acute Lymphoblastic Leukemia

Bingqing Tang, Zhixiang Wang, Dainan Lin, Xianjun He, Zihong Cai, Kangyu Huang, Xuan Zhou, Ren Lin, Liu Xiaoli, Na Xu, Fen Huang, Jing Sun, Qifa Liu, Hongsheng Zhou

Blood (2021) 138 (Supplement 1): 4474.

https://doi.org/10.1182/blood-2021-154271

Published: 2021

Journal Articles

Combination of Homoharringtonine with Venetoclax and Azacitidine Excerts Better Treatment Response in Relapsed /Refractory Acute Myeloid Leukemia

Guopan Yu, Na Xu, Fen Huang, Zhiping Fan, MD, Hui Liu, Pengcheng Shi, Hongsheng Zhou, MD PhD, Zhixiang Wang, Yu Zhang, Qifa Liu, MD

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-138676

Published: 2020

NARROW

Prognostic Impact of TP53 Mutation in Adult Acute Lymphoblastic Leukemia Treated with Pediatric-Inspired Regimen

Treatment of Acute Lymphoblastic Leukemia with PDT Regimen Improves the Prognosis of Newly Diagnosed Central Nervous System Leukemia

CRM1/XPO1-FOXO1 Pathway Is Associated with Clinical Outcome and Represents a Promising Target in B-Cell Acute Lymphocytic Leukemia

Evaluation of the Effectiveness of Antifungal Prophylaxis in Adult Acute Lymphoblastic Leukemia during Induction Chemotherapy

Allo-HSCT Improved Outcome of High Risk ALL in Pediatric-Inspired PDT-ALL-2016 Cohort

Frontline Combination of 3 rd Generation TKI Olverembatinib and Blinatumomab for Ph+/Ph-like ALL Patients

The Pediatric-Inspired Regimen Improved Quality and Quantity of Life for Patients with Acute Lymphoblastic Leukemia，Beyond Age, Risk Stratification, and Hematopoietic Stem Cell Transplantation

Olverembatinib(HQP1351)-Based Therapy in Adults with Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Advanced Chronic Myeloid Leukemia: Results of the Real-Life Study

CD19-Specific CAR NK Cells Coexpressing IL-21 Exhibit Superior Expansion and Antitumor Activity Against CD19-Postive Lymphoma

Efficacy and Safety of TLR2 Co-Stimulated CAR T Cells in CD19-Positive Lymphoid Malignancies with Central Nervous System Involvement

Maintenance Therapy with Chidamide Decreases the Relapse in Fusion Gene-Positive AML Patients with MRD-Positive or ELN-High Risk

Venetoclax in Combination with Homoharringtonine and Cytarabine in the Treatment of Relapsed/Refractory Early T-Cell Precursor Acute Lymphoblastic Leukaemia: A Single Arm, Multicenter, Prospective, Phase II, Pilot Trial

Chemotherapy or Hematopoietic Stem Cell Transplantation in B-Lineage Acute Lymphoblastic Leukemia Patients Based on IKZF1 and MRD Status

Prognostic Significance of Epigenetic Modifiers Gene Mutations in Adult Acute Lymphoblastic Leukemia at Diagnosis

Sustained Remission and Decreased Severity of CAR T-Cell Related Adverse Events: A Pivotal Study Report of CNCT19 (inaticabtagene autoleucel) Treatment in Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-Cell ALL) in China

Dynamics of Minimal Residual Disease Defines a Novel Risk-Classification and the Role of Allo-HSCT in Adult Ph-Negative B Cell Acute Lymphoblastic Leukemia

Metabolic Feature Profiling and Metabolic Vulnerability Targeting in B-Cell Lymphoblastic Leukemia

HDACi Targets IKZF1 Deletion High-Risk Acute Lymphoblastic Leukemia By Inducing IKZF1 Expression and Rescuing IKZF1 Function in Vitro and In Vivo

IKZF1deletions Coupled with CD20 Expression Represents a Novel High-Risk Subtype in Adult B-Cell Progenitor Acute Lymphoblastic Leukemia

Combination of Homoharringtonine with Venetoclax and Azacitidine Excerts Better Treatment Response in Relapsed /Refractory Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only